Science.

This is the place to learn all about the science behind our services – from general background about antibodies, to details about our unique technology, to real world problems that our clients have solved.

Latest post:

NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens

On-Demand Webinar

Trick or Treat: Unmasking Antibody Reproducibility in Life Sciences

Fill out the form below to receive a link to the recording.

De Novo Protein Sequencing of Antibodies for Identification of Neutralizing Antibodies in Human Plasma Post SARS-CoV-2 Vaccination

Integrating AI and HDX-MS for Antibody Epitope Mapping

Identifying CDRs by Antibody Sequencing

All posts >>

Applications

Webinars

Monthly webinar series featuring guest speakers and technology deep dives. View on demand.

View on demand

Case studies

Studies, publications, posters and technical notes that used our services and technology to achieve great things.

Literature review

Browse by application area

Find content about your specific industry niche – e.g. antibody discovery, protein engineering, IVD, veterinary medicine, etc.

Applications pages

Rapid Novor Technology

Epitope Mapping: Alanine Scanning Mutagenesis vs. HDX-MS

Genya Gorshtein2024-06-10T13:42:22-04:00Tags: Antibody characterization, Antibody drug discovery, antibody epitopes, Antibody selection, Antibody therapeutics, Binding epitopes, Epitope mapping, HDX-MS, Technology|

Epitope Binning With SPR For Antibody Drug Discovery

Genya Gorshtein2024-05-30T12:50:11-04:00Tags: Antibody characterization, Antibody drug discovery, Antibody selection, Antibody therapeutics, Binding epitopes, Epitope binning, Epitope mapping, Fragments, kinetics, SPR, Technology|

Ask Our Experts: Navigating Antibody Characterization through LC-MS

Genya Gorshtein2024-07-12T09:51:00-04:00Tags: Antibody characterization, Antibody development, cell line development, De novo sequencing, Disulfide bond, Monoclonal antibody, Peptide mapping, Post-translational modification, Recombinant expression, Technology|

More about our technology >>

Antibody Learning Center

Antibody Humanization Strategies, Challenges, and Innovations

Jenna Kerry2024-11-06T17:37:43-05:00Tags: AI, antibody, Antibody characterization, Antibody development, Antibody discovery, Antibody drug discovery, Antibody engineering, antibody epitopes, antibody function, Antibody humanization, Antibody therapeutics, B cell sequencing, Immunotherapy, Learning, Polyclonal antibody sequencing|

Comparing Epitope Mapping Methods

Genya Gorshtein2024-10-25T12:53:30-04:00Tags: Antibody Epitope, Binding Epitope, Cryo-EM, Epitope mapping, Epitope Mapping Methods, FPOP-MS, functional characterization, HDX, HDX-MS, HDX-MS Epitope Mapping, Learning, Method Comparison, Paratope Mapping, X-Ray, XL-MS|

Trick or Treat: Unmasking Antibody Reproducibility in Life Sciences

Genya Gorshtein2024-10-31T15:26:06-04:00Tags: antibody reproducibility, Learning, Monoclonal antibody, pAb, Polyclonal antibody, Polyclonal antibody sequencing, Recombinant expression, REpAb, Reproducibility, reproducibility crisis, Target validation, tool antibodies|

Visit the learning center >>

Press Releases & News

De Novo Antibody Sequencing Reveals Novel Functional and Neutralizing Antibodies Post-SARS-CoV-2 Vaccination

Rapid Novor Teams Up with PMCC to Evaluate EasyM™ for Multiple Myeloma Minimal Residual Disease Monitoring

Rapid Novor and MAbSilico Partner for World’s First AI-Guided Epitope Mapping Service for Antibodies

More news >>

Upcoming Conferences.

View All Upcoming COnferences

Talk to Our Scientists.

We Have Sequenced 9000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.

Science.

NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens

On-Demand Webinar

Featured Posts

De Novo Protein Sequencing of Antibodies for Identification of Neutralizing Antibodies in Human Plasma Post SARS-CoV-2 Vaccination

Integrating AI and HDX-MS for Antibody Epitope Mapping

Identifying CDRs by Antibody Sequencing

All posts >>

Applications

Webinars

Case studies

Browse by application area

Rapid Novor Technology

Epitope Mapping: Alanine Scanning Mutagenesis vs. HDX-MS

Epitope Binning With SPR For Antibody Drug Discovery

Ask Our Experts: Navigating Antibody Characterization through LC-MS

More about our technology >>

Antibody Learning Center

Antibody Humanization Strategies, Challenges, and Innovations

Comparing Epitope Mapping Methods

Trick or Treat: Unmasking Antibody Reproducibility in Life Sciences

Visit the learning center >>

Press Releases & News

De Novo Antibody Sequencing Reveals Novel Functional and Neutralizing Antibodies Post-SARS-CoV-2 Vaccination

Rapid Novor Teams Up with PMCC to Evaluate EasyM™ for Multiple Myeloma Minimal Residual Disease Monitoring

Rapid Novor and MAbSilico Partner for World’s First AI-Guided Epitope Mapping Service for Antibodies

More news >>

Upcoming Conferences.

Talk to Our Scientists.

We Have Sequenced 9000+ Antibodies and We Are Eager to Help You.

Services

Science

About

Other programs

Services

Applications

Science

About